Sri Sai Subramanyam Challa, “EVALUATING THE EFFECTIVENESS OF RISK-BASED APPROACHES IN STREAMLINING THE REGULATORY APPROVAL PROCESS FOR NOVEL THERAPIES”, J Popl Ther Clin Pharmacol, vol. 28, no. 2, pp. 436–448, Aug. 2021, doi: 10.53555/jptcp.v28i2.7421.